These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24919218)

  • 1. [Advancement of researches on association of non-alcoholic fatty liver disease with type 2 diabetes mellitus].
    Gao X; Wang S
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):161-4. PubMed ID: 24919218
    [No Abstract]   [Full Text] [Related]  

  • 2. Interfering parameters in nonalcoholic fatty liver disease fibrosis score.
    Sertoglu E; Kayadibi H; Uyanik M
    Liver Int; 2015 Jan; 35(1):285. PubMed ID: 25102955
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and diabetes.
    Reyes-García R; Rozas-Moreno P; Llamoza-Torres CJ; Mezquita-Raya P
    Med Clin (Barc); 2017 Jan; 148(1):33-38. PubMed ID: 27751514
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis and diabetes.
    Caballeria J; Caballeria L
    Endocrinol Nutr; 2016 Oct; 63(8):377-9. PubMed ID: 27423933
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to Dr. Sertoglu and colleagues.
    Petta S; Vanni E; Craxì A
    Liver Int; 2015 Jan; 35(1):285-6. PubMed ID: 25131005
    [No Abstract]   [Full Text] [Related]  

  • 7. A Study of Non?Alcoholic Fatty Liver Disease in Type II Diabetes.
    Hussain MA; Prahlad B; Fazullulah S
    J Assoc Physicians India; 2020 Jan; 68(1):90. PubMed ID: 31979848
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of antidiabetic drugs in patients with non-alcoholic fatty liver disease].
    Yang G; Yuan L
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):174-7. PubMed ID: 24919223
    [No Abstract]   [Full Text] [Related]  

  • 9. Astaxanthin Improves Nonalcoholic Fatty Liver Disease in Werner Syndrome with Diabetes Mellitus.
    Takemoto M; Yamaga M; Furuichi Y; Yokote K
    J Am Geriatr Soc; 2015 Jun; 63(6):1271-3. PubMed ID: 26096415
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-alcoholic steatohepatitis in type 2 diabetes mellitus.
    Gupte P; Amarapurkar D; Agal S; Baijal R; Kulshrestha P; Pramanik S; Patel N; Madan A; Amarapurkar A; Hafeezunnisa
    J Gastroenterol Hepatol; 2004 Aug; 19(8):854-8. PubMed ID: 15242486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-alcoholic fatty liver disease in type 2 diabetes: a joint statement of the Chilean Hepatology and Diabetology Societies].
    Arab JP; Castro L; Gómez PC; Vignolo P; Arrese M; Barrera F; Castro F; Díaz LA; Donoso A; Elgueta K; González K; González MI; Moreno M; Lazarte R; Poniachik J; Salman P; Valderas JP
    Rev Med Chil; 2021 Sep; 149(9):1360-1371. PubMed ID: 35319691
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of non alcoholic fatty liver disease and associated factors?
    Moran S
    Ann Hepatol; 2022; 27(2):100659. PubMed ID: 35007769
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver-heart connection in diabetes mellitus.
    Yip TC; Wong VW; Wong GL
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1385-1386. PubMed ID: 34105827
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: III. Relation with Type II diabetes: regulation by hepatokines].
    Misu H
    Nihon Naika Gakkai Zasshi; 2016 Jan; 105(1):25-30. PubMed ID: 27266040
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?
    Williams DM; Krishnamoorthy SV; Ch'ng CL; Stephens JW; Min T
    Obesity (Silver Spring); 2022 May; 30(5):969-970. PubMed ID: 35373513
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to: "Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?".
    Barb D; Cusi K
    Obesity (Silver Spring); 2022 May; 30(5):971-972. PubMed ID: 35394120
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults.
    Ye BS
    Clin Mol Hepatol; 2022 Jul; 28(3):481-482. PubMed ID: 35570004
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.
    Hwang ST; Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Rhee EJ; Oh KW; Lee WY; Jin W
    Intern Med J; 2010 Jun; 40(6):437-42. PubMed ID: 19460054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy].
    Lazebnik LB; Zvenigorodskaia LA; Egorova EG; Mel'nikova NV; Khomeriki SG
    Eksp Klin Gastroenterol; 2009; (8):4-11. PubMed ID: 20469672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the editor: Circulating thrombospondin-2 as a biomarker in patients with NAFLD with and without diabetes-Are we convinced yet?
    Lee CH; Lui DTW; Lam KSL
    Hepatology; 2022 May; 75(5):1340. PubMed ID: 35075677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.